OBJECTIVE: The purpose of this randomized, controlled, parallel group study was to characterize the relationships between dosages of stearidonic acid (SDA) and eicosapentaenoic acid (EPA), and incorporation of EPA into red blood cell (RBC) membranes over time. METHODS:Healthy subjects (n=131) receivedcapsules with placebo (safflower oil), SDA (0.43, 1.3, 2.6, or 5.2 g/d) or EPA (0.44, 1.3, or 2.7 g/d) for 12 weeks. RBC fatty acids were analyzed biweekly. RESULTS:RBC %EPA increased in all EPA and SDA groups (p<0.02 vs. control) except the 0.43 g/d SDA group (p=0.187). For theoretical intakes of EPA of 0.25, 0.5, and 0.89 g/d, the amounts of SDA needed to achieve equivalent RBC EPA enrichment were 0.61, 1.89, and 5.32 g/d (conversion efficiencies of 41%, 26%, and 17%), respectively. CONCLUSIONS:SDA increased RBC %EPA in a dosage and time-dependent manner at intakes as low as 1.3 g/d.
RCT Entities:
OBJECTIVE: The purpose of this randomized, controlled, parallel group study was to characterize the relationships between dosages of stearidonic acid (SDA) and eicosapentaenoic acid (EPA), and incorporation of EPA into red blood cell (RBC) membranes over time. METHODS: Healthy subjects (n=131) received capsules with placebo (safflower oil), SDA (0.43, 1.3, 2.6, or 5.2 g/d) or EPA (0.44, 1.3, or 2.7 g/d) for 12 weeks. RBC fatty acids were analyzed biweekly. RESULTS: RBC %EPA increased in all EPA and SDA groups (p<0.02 vs. control) except the 0.43 g/d SDA group (p=0.187). For theoretical intakes of EPA of 0.25, 0.5, and 0.89 g/d, the amounts of SDA needed to achieve equivalent RBC EPA enrichment were 0.61, 1.89, and 5.32 g/d (conversion efficiencies of 41%, 26%, and 17%), respectively. CONCLUSIONS:SDA increased RBC %EPA in a dosage and time-dependent manner at intakes as low as 1.3 g/d.
Authors: Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair Journal: Eur J Nutr Date: 2012-06-23 Impact factor: 5.614
Authors: Chesney K Richter; Kate J Bowen; Dariush Mozaffarian; Penny M Kris-Etherton; Ann C Skulas-Ray Journal: Lipids Date: 2017-09-27 Impact factor: 1.880
Authors: Chesney K Richter; Karl Stessy Bisselou; Tara M Nordgren; Lynette Smith; Adams Kusi Appiah; Nicholas Hein; Ann Anderson-Berry; Penny Kris-Etherton; Corrine Hanson; Ann C Skulas-Ray Journal: Lipids Date: 2019-04 Impact factor: 1.880
Authors: Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; William S Harris Journal: J Clin Psychiatry Date: 2019-06-04 Impact factor: 4.384
Authors: Ann C Skulas-Ray; Michael R Flock; Chesney K Richter; William S Harris; Sheila G West; Penny M Kris-Etherton Journal: Nutrients Date: 2015-08-04 Impact factor: 5.717
Authors: Celia G Walker; Annette L West; Lucy M Browning; Jackie Madden; Joanna M Gambell; Susan A Jebb; Philip C Calder Journal: Nutrients Date: 2015-08-03 Impact factor: 5.717